1. P21 Obeticholic acid improves hepatic fibroinflammation as assessed by multiparametric MRI: interim results of the REGENERATE trial. (28th September 2020) Authors: Anstee, Quentin; Digpal, Kuldip Journal: Gut Issue: Volume 69(2020)Supplement 1 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P20 Obeticholic acid improves experimental non-invasive markers of non-alcoholic steatohepatitis and advanced fibrosis: results of a secondary analysis from the month-18 interim analysis of the REGENERATE study. (28th September 2020) Authors: Digpal, Kuldip; Anstee, Quentin Journal: Gut Issue: Volume 69(2020)Supplement 1 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O7 Exploring genetic variation of PDCD1, which encodes T-cell receptor PD-1, in patients with non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). (28th September 2020) Authors: Darlay, Rebecca; Eldafashi, Nardeen; McStraw, Nikki Martina; Cordell, Heather; Watson, Robyn; McCain, Misti Vanette; Mauricio-Muir, Joao; Shukla, Ruchi; Dufour, Jean-Francois; Valenti, Luca; Anstee, Quentin; Reeves, Helen Journal: Gut Issue: Volume 69(2020)Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IDDF2019-ABS-0133 Routinely available noninvasive tests discriminate advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib. (June 2019) Authors: Wong, Vincent Wai-Sun; Anstee, Quentin; Lawitz, Eric; Alkhouri, Naim; Romero-Gomez, Manuel; Okanoue, Takeshi; Trauner, Michael; Kersey, Kathryn; Li, Georgia; Subramanian, Mani; Myers, Robert; Djedjos, Stephen; Han, Ling; Nguyen, Tuan; Kohli, Anita; Bzowej, Natalie; Younes, Ziad; Sarin, Shiv; Shif... Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IDDF2019-ABS-0131 Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials. (June 2019) Authors: Wong, Vincent Wai-Sun; Younossi, Zobair; Lawitz, Eric; Alkhouri, Naim; Romero-Gomez, Manuel; Okanoue, Takeshi; Trauner, Michael; Kersey, Kathryn; Li, Georgia; Subramanian, Mani; Myers, Robert; Djedjos, Stephen; Han, Ling; Chen, Guang; Nguyen, Tuan; Kohli, Anita; Bzowej, Natalie; Younes, Ziad; Sar... Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease. Issue 1 (29th July 2021) Authors: Scragg, Jadine; Hallsworth, Kate; Taylor, Guy; Cassidy, Sophie; Haigh, Laura; Boyle, Marie; Anstee, Quentin; McPherson, Stuart; Avery, Leah Journal: BMJ open gastroenterology Issue: Volume 8:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey. Issue 4 (28th April 2017) Authors: Sheridan, David A; Aithal, Guru; Alazawi, William; Allison, Michael; Anstee, Quentin; Cobbold, Jeremy; Khan, Shahid; Fowell, Andrew; McPherson, Stuart; Newsome, Philip N; Oben, Jude; Tomlinson, Jeremy; Tsochatzis, Emmanouil Journal: Frontline gastroenterology Issue: Volume 8:Issue 4(2017) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary–secondary care interface. Issue 1 (8th February 2023) Authors: McPherson, Stuart; Jarvis, Helen; McGonigle, John; Bedlington, Joan; Dean, Jill; Hallsworth, Kate; Hanon, Elodie; Liddle, Trevor; Luvai, Ahai; Mansour, Dina; Patel, Preya; Renwick, Laura; Teare, Dawn; Tanney, Christina; Anstee, Quentin Journal: BMJ open gastroenterology Issue: Volume 10:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗